Iovino Michele, Messana Tullio, De Pergola Giovanni, Iovino Emanuela, Dicuonzo Franca, Guastamacchia Edoardo, Giagulli Vito Angelo, Triggiani Vincenzo
Interdisciplinary Department of Medicine-Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari "Aldo Moro", Bari, Italy.
UOC Neuropsichiatria Infantile, IRCSS- Istituto Scienze Neurologiche, Bologna, Italy.
Endocr Metab Immune Disord Drug Targets. 2018;18(4):341-347. doi: 10.2174/1871530318666180220104900.
Although the neurohypophyseal hormones vasopressin (VP) and oxytocin (OT) are mostly known for their role respectively in antidiuresis, and in labour, lactation and maternal behavior, both might exert widespread influences either on emotion and cognition in healthy subjects, showing some gender-related differences. They interact with each other facilitating shifts between positive socially- oriented and defensive states. In fact, VP amplifies the reactivity to stressors showing also beneficial effects on attention, verbal learning as well as memory, whereas OT reduces the amplitude of the stress response, improves emotion processing, and can play a negative effect on memory and verbal learning in healthy individuals. Several data indicate the possible involvement of these neuropeptides in the pathophysiology of psychiatric conditions involving social interactions, such as autism, as well as in schizophrenia and depression. The aim of this paper is to review the literature relating to the role played by neurohypophyseal hormones in neuropsychiatric disorders.
We analyzed the best of published literature dealing with the relationships between neurohypophyseal hormones and neuropsychiatric conditions like autism (AD), major depressive disorder (MDD), bipolar disorder (BD) and schozophrenia, identifying keywords and MeSH terms in Pubmed and then searching them. The last search was performed on December 2017.
Several studies indicate a role played by OT and VP in AD, schizophrenia, MDD and BD. Even if conflicting data have been reported, several mechanisms may be involved in these behavioral diseases, such as differences in aminoacid sequence and peptide biological activity, neurotransmission and genetic disorders involving OT and VP receptors.
The involvment of VP and OT in neurpopsychiatric disorders can support a possible beneficial therapy with OT or with VP antagonists. The target may be obtained using effective drug delivery methods as well as the association with other drugs.
虽然神经垂体激素血管加压素(VP)和催产素(OT)分别主要因其在抗利尿以及分娩、泌乳和母性行为中的作用而为人所知,但二者可能对健康受试者的情绪和认知产生广泛影响,且存在一些性别相关差异。它们相互作用,促进积极的社交导向状态和防御状态之间的转换。事实上,VP会增强对应激源的反应性,对注意力、言语学习和记忆也有有益影响,而OT会降低应激反应的幅度,改善情绪处理,并且可能对健康个体的记忆和言语学习产生负面影响。多项数据表明,这些神经肽可能参与了涉及社交互动的精神疾病(如自闭症)以及精神分裂症和抑郁症的病理生理过程。本文旨在综述有关神经垂体激素在神经精神疾病中所起作用的文献。
我们分析了已发表的关于神经垂体激素与自闭症(AD)、重度抑郁症(MDD)、双相情感障碍(BD)和精神分裂症等神经精神疾病之间关系的最佳文献,在PubMed中确定关键词和医学主题词(MeSH),然后进行检索。最后一次检索于2017年12月进行。
多项研究表明OT和VP在AD、精神分裂症、MDD和BD中发挥作用。即使有相互矛盾的数据报道,但这些行为疾病可能涉及多种机制,如氨基酸序列和肽生物活性的差异、神经传递以及涉及OT和VP受体的遗传疾病。
VP和OT参与神经精神疾病可能支持使用OT或VP拮抗剂进行有益治疗。可通过有效的药物递送方法以及与其他药物联合来实现这一目标。